Home » Topics » BioWorld Science

BioWorld Science
RSS

Italian researchers present new PTPN11 inhibitors

Feb. 26, 2021

Amgen discovers new KIF18A inhibitors

Feb. 26, 2021

First patient dosed in phase III study of eftansomatropin alfa in China

Feb. 26, 2021

Janssen Pharmaceutica synthesizes new compounds for HBV infection

Feb. 26, 2021

Gene variants can increase fat, decrease cardiometabolic risk

Feb. 26, 2021

Well Marker Bio presents new MST1R inhibitors

Feb. 26, 2021

Repure Life Science patents p300 inhibitors

Feb. 26, 2021

Initiation of phase IIa study evaluating BGE-117 in elderly with unexplained anemia

Feb. 26, 2021

ESSA Pharma and Astellas collaborate to investigate EPI-7386 plus enzalutamide in mCRPC

Feb. 26, 2021

Altimmune initiates enrollment in phase I study of AdCOVID intranasal COVID-19 vaccine candidate

Feb. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026